The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, Y.
Right arrow Articles by Waer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, Y.
Right arrow Articles by Waer, M.

The Journal of Immunology, Vol 158, Issue 12 5658-5667, Copyright © 1997 by American Association of Immunologists


ARTICLES

Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses

Y Lin, M Vandeputte and M Waer
Division of Nephrology, University of Leuven, Belgium.

Hyperacute, complement-mediated xenograft (Xg) rejection is a first major hurdle for xenotransplantation. Thereafter, cellular immunity, including T and B lymphocytes, NK cells, and macrophages may become involved as well. In the present study, hamster heart Xgs were performed in Leflunomide (LF)-treated nude rats. These animals, which are genetically T cell deficient, are known to have a strong NK activity. Moreover, xenoantibody (XAb) formation by B lymphocytes was previously shown to be blocked in nude rats by LF. Hence, this model was well suited to study the role of NK cells and macrophages in Xg rejection. Despite a total suppression of XAb formation, LF-treated nude rats rejected hamster heart Xgs at a same speed (3 days) as untreated nude rats. NK cells played a major role in this rejection process. Indeed, an NK cell-dominated cellular infiltration was noticed in the rejected Xgs and the addition of an anti-NK cell serum, anti- Asialo GM-1 (ASGM-1), to the LF treatment resulted in a significant delay of Xg rejection (from 3 days to 6 days; p < 0.0001) that seemed to be mediated by activated macrophages because 1) spleens from rejecting animals showed an increased percentage of macrophages (ED1+ or ED2+) and 2) rejected Xgs were infiltrated predominantly by macrophages. Moreover, splenocytes taken from rats that rejected Xgs despite a treatment with LF + ASGM-1 provoked an acceleration of Xg rejection when transferred to newly transplanted LF + ASGM-1-treated nude rats, and finally, the latter accelerating effect disappeared when macrophages were first depleted from the adoptively transferred splenocytes. This study thus shows that NK cells and macrophages can be activated in the absence of T cells or XAbs to directly reject Xgs.


This article has been cited by other articles:


Home page
J. Immunol.Home page
B. G. Lilienfeld, C. Garcia-Borges, M. D. Crew, and J. D. Seebach
Porcine UL16-Binding Protein 1 Expressed on the Surface of Endothelial Cells Triggers Human NK Cytotoxicity through NKG2D
J. Immunol., August 15, 2006; 177(4): 2146 - 2152.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Forte, B. G. Lilienfeld, B. C. Baumann, and J. D. Seebach
Human NK Cytotoxicity against Porcine Cells Is Triggered by NKp44 and NKG2D
J. Immunol., October 15, 2005; 175(8): 5463 - 5470.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. D. Peterson, R. Jin, S. Hyduk, P. Duchesneau, M. I. Cybulsky, and T. K. Waddell
Monocyte Adhesion to Xenogeneic Endothelium during Laminar Flow Is Dependent on {alpha}-Gal-Mediated Monocyte Activation
J. Immunol., June 15, 2005; 174(12): 8072 - 8081.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. J. Gordon, L. S. Wicker, L. B. Peterson, D. V. Serreze, T. G. Markees, L. D. Shultz, A. A. Rossini, D. L. Greiner, and J. P. Mordes
Autoimmune Diabetes and Resistance to Xenograft Transplantation Tolerance in NOD Mice
Diabetes, January 1, 2005; 54(1): 107 - 115.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Miyagawa, T. Kubo, K. Matsunami, T. Kusama, K. Beppu, H. Nozaki, T. Moritan, C. Ahn, J. Y. Kim, D. Fukuta, et al.
Delta-Short Consensus Repeat 4-Decay Accelerating Factor (DAF: CD55) Inhibits Complement-Mediated Cytolysis but Not NK Cell-Mediated Cytolysis
J. Immunol., September 15, 2004; 173(6): 3945 - 3952.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Yi, W. J. Hawthorne, A. M. Lehnert, H. Ha, J. K. W. Wong, N. van Rooijen, K. Davey, A. T. Patel, S. N. Walters, A. Chandra, et al.
T Cell-Activated Macrophages Are Capable of Both Recognition and Rejection of Pancreatic Islet Xenografts
J. Immunol., March 1, 2003; 170(5): 2750 - 2758.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Z. E. Holzknecht, K. L. Kuypers, T. B. Plummer, J. Williams, M. Bustos, G. J. Gores, G. J. Brunn, and J. L. Platt
Apoptosis and Cellular Activation in the Pathogenesis of Acute Vascular Rejection
Circ. Res., December 13, 2002; 91(12): 1135 - 1141.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Costa, D. F. Barber, and W. L. Fodor
Human NK Cell-Mediated Cytotoxicity Triggered by CD86 and Gal{alpha}1,3-Gal Is Inhibited in Genetically Modified Porcine Cells
J. Immunol., April 15, 2002; 168(8): 3808 - 3816.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Tanaka, K.-h. Sonoda, and J. W. Streilein
Acute Rejection of Orthotopic Corneal Xenografts in Mice Depends on CD4+ T Cells and Self-Antigen-Presenting Cells
Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2878 - 2884.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Tsuyuki, J. A. Horvath-Arcidiacono, and E. T. Bloom
Effect of Redox Modulation on Xenogeneic Target Cells: The Combination of Nitric Oxide and Thiol Deprivation Protects Porcine Endothelial Cells from Lysis by IL-2-Activated Human NK Cells
J. Immunol., March 15, 2001; 166(6): 4106 - 4114.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Xia, J. Goebels, O. Rutgeerts, M. Vandeputte, and M. Waer
Transplantation Tolerance and Autoimmunity After Xenogeneic Thymus Transplantation
J. Immunol., February 1, 2001; 166(3): 1843 - 1854.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Tanaka, J. Yamada, and J. W. Streilein
Xenoreactive CD4+ T Cells and Acute Rejection of Orthotopic Guinea Pig Corneas in Mice
Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1827 - 1832.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
Y. Lin, M. P. Soares, K. Sato, E. Csizmadia, S. C. Robson, N. Smith, and F. H. Bach
Long-Term Survival of Hamster Hearts in Presensitized Rats
J. Immunol., May 1, 2000; 164(9): 4883 - 4892.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. Nakamura, C. Naper, E. C. Niemi, S. C. Spusta, B. Rolstad, G. W. Butcher, W. E. Seaman, and J. C. Ryan
Natural Killing of Xenogeneic Cells Mediated by the Mouse Ly-49D Receptor
J. Immunol., November 1, 1999; 163(9): 4694 - 4700.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Brouard, B. Vanhove, K. Gagne, A. Neumann, P. Douillard, A. Moreau, C. Cuturi, and J. P. Soulillou
T Cell Repertoire Alterations of Vascularized Xenografts
J. Immunol., March 15, 1999; 162(6): 3367 - 3377.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Lin, M. P. Soares, K. Sato, K. Takigami, E. Csizmadia, J. Anrather, and F. H. Bach
Rejection of Cardiac Xenografts by CD4+ or CD8+ T Cells
J. Immunol., January 15, 1999; 162(2): 1206 - 1214.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. A. ROSSINI, D. L. GREINER, and J. P. MORDES
Induction of Immunologic Tolerance for Transplantation
Physiol Rev, January 1, 1999; 79(1): 99 - 141.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. H. Idris, K. Iizuka, H. R.C. Smith, A. A. Scalzo, and W. M. Yokoyama
Genetic Control Of Natural Killing and In Vivo Tumor Elimination by the Chok Locus
J. Exp. Med., December 21, 1998; 188(12): 2243 - 2256.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Miyatake, K. Sato, K. Takigami, N. Koyamada, W. W. Hancock, H. Bazin, D. Latinne, F. H. Bach, and M. P. Soares
Complement-Fixing Elicited Antibodies Are a Major Component in the Pathogenesis of Xenograft Rejection
J. Immunol., April 15, 1998; 160(8): 4114 - 4123.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Lin, M. Vandeputte, and M. Waer
Accommodation and T-Independent B Cell Tolerance in Rats With Long Term Surviving Hamster Heart Xenografts
J. Immunol., January 1, 1998; 160(1): 369 - 375.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.